Pipeline and therapeutic focus
CytoTools’ diverse product pipeline comprises proprietary small molecules and biologics which have the potential to provide new treatment options in dermatology, cardiology and angiology, urology and oncology.
Lead clinical product – DermaPro®
Our main product DermaPro® has received market approval subjected to local production in India in March 2017. It has demonstrated rapid and effective wound healing in patients with diabetic foot during Phase III clinical trials. Phase III clinical trials in Europe for venous leg ulcer and diabetic foot ulcer must be repeated.
cytotools_logo-1
Loading...
No Records Found
Sorry, no records were found. Please adjust your search criteria and try again.
We use cookies to personalize content and ads, to provide social media features and to analyze our website traffic. We also share information about your use of our website with our social media, advertising, and analytics partners. Read more about how we use cookies by clicking on 'Privacy Policy'. Click the "I agree" button to continue to use this site.I agreePrivacy Policy
